Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience ; volume:16 ; number:1 ; day:18 ; month:7 ; year:2016 ; pages:1-7 ; date:12.2016
BMC cancer ; 16, Heft 1 (18.7.2016), 1-7, 12.2016
- Creator
-
Kim, Alexander Y.
- Contributor
-
Unger, Keith
Wang, Hongkun
Pishvaian, Michael J.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2552-2
- URN
-
urn:nbn:de:1111-201607229854
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Alexander Y.
- Unger, Keith
- Wang, Hongkun
- Pishvaian, Michael J.
- SpringerLink (Online service)
Other Objects (12)
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC